Hennion & Walsh Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
|
+$20.4M |
| 2 |
Nuveen Municipal Credit Income Fund
NZF
|
+$2.51M |
| 3 |
LEO
BNY Mellon Strategic Municipals
LEO
|
+$2.5M |
| 4 |
Invesco Municipal Opportunity Trust
VMO
|
+$2.5M |
| 5 |
DMB
BNY Mellon Municipal Bond Infrastructure Fund
DMB
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$20.5M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$4.42M |
| 3 |
BlackRock MuniHoldings Fund
MHD
|
+$4.06M |
| 4 |
EIM
Eaton Vance Municipal Bond Fund
EIM
|
+$3.28M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$3.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.25% |
| 2 | Financials | 10.1% |
| 3 | Technology | 8.65% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.24% |
Similar funds
Hennion & Walsh Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Hennion & Walsh Asset Management held 854 positions worth $1.57B, down 7% from $1.69B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Hennion & Walsh Asset Management's Q3 2023 filing shows 57 new, 321 increased, 405 reduced and 55 closed positions. Its largest new stake was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M. The largest sale was Schwab US Dividend Equity ETF, an estimated $20.5M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Technology.
- Hennion & Walsh Asset Management's largest Q3 2023 buy was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M.
- Hennion & Walsh Asset Management added most to Nuveen Municipal Credit Income Fund in Q3 2023, an estimated $2.51M increase.
- Hennion & Walsh Asset Management's biggest Q3 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $20.5M.
- Hennion & Walsh Asset Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $4.42M.
- Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.57B portfolio in Q3 2023.
- Hennion & Walsh Asset Management opened 57 new positions and closed 55 in Q3 2023.
- Hennion & Walsh Asset Management's portfolio value fell 7% quarter-over-quarter to $1.57B.
Based on Hennion & Walsh Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.